Toggle Offcanvas
...
 
Bortezomib Tenders

Bortezomib Tenders

View Bortezomib tenders, RFPs and contracts. Bid on readily available Bortezomib tenders with the best and most comprehensive tendering platform, since 2002.
Bortezomib is a proteasome inhibitor mainly used for treating multiple myeloma and mantle cell lymphoma. It disrupts protein degradation in cancer cells, leading to their accumulation and eventual death.

Bidding for Bortezomib tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Bortezomib.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Bortezomib market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Bortezomib tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

10 Live Notices for Bortezomib Tenders

Showing 1 to 10

Delivery Of Medicinal Products
country Poland
posting date15 Jul 2025
deadline19 Aug 2025
Request For International Offers To Purchase Hospital Medicines For The Year 2026-2027 (I/2027-2026)
country Tunisia
posting date12 Jul 2025
deadline26 Aug 2025
L01XA03 Oxaliplatin concentrate for solution for infusion 100 mg vial 96
country North Macedonia
posting date02 Jul 2025
deadline28 Jul 2025
Oncology Drugs
country Romania
posting date27 Jun 2025
deadline04 Aug 2025
Framework Agreement Parenteral Cytostatics
country Belgium
posting date26 Jun 2025
deadline18 Aug 2025
Framework Agreement Parenteral Cytostatics
country Belgium
posting date12 Jun 2025
deadline31 Jul 2025
Open-House Drug Discount Contracts In Accordance With Section 130A (8C) Sgb V For The Kv-Region Berlin
country Germany
posting date07 Mar 2025
deadline21 Feb 2026
Open-House Drug Discount Contracts In Accordance With Section 130A (8C) Sgb V For The Kv Region Mecklenburg-Western Pomerania
country Germany
posting date06 Mar 2025
deadline21 Feb 2026
Open-House Drug Discount Contracts In Accordance With Section 130A (8C) Sgb V For The Kv Region Brandenburg
country Germany
posting date06 Mar 2025
deadline21 Feb 2026
Injection Bortezomib 2Mg Vial
country India
posting date21 Jul 2025
deadline23 Jul 2025

Share Share this page